Device Group
Devicenon-implanted, vaginal electrical stimulation device
NCT Number: NCT07195656
A study to evaluate the safety and effectiveness of FemPulse System
Interested in participating?
Request Info21 year and older
Female
Interventional
Not applicable
Cedars Sinai, Beverly Hills, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Key Inclusion Criteria:
Key Exclusion Criteria:
non-implanted, vaginal electrical stimulation device
OAB Medication
Time frame: 6 months
Difference in mean change between device and medication groups in number of voids per day (VPD)
Contact information is provided by the study sponsor or research team.
FemPulse Corporation
Industry
Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II
Acronym: EVANESCE-II
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07335484
Digestive System Diseases, Fecal Incontinence
North Adelaide, South Australia, Australia
View Trial DetailsNCT06789406
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Chicago, Illinois, United States
View Trial DetailsNCT07405554
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Skokie, Illinois, United States
View Trial DetailsNCT07193407
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Kogarah, New South Wales, Australia
View Trial Details